Figure 1. The proposed model. CRF-R2, corticotrophin-releasing factor receptor type 2; DRN, dorsal raphe nucleus; GHSR, ghrelin receptor; GR, glucocorticoid receptor; ERβ, estrogen receptor β; LS, lateral septal nucleus; NPY-Y1 and Y5, neuropeptide Y receptor Y1 and Y5; ObR, leptin receptor; VMH, ventromedial hypothalamic nucleus.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.